Virus / Medicine / Health / Biology / BioPharma / Biotech / Biologic / Biological / BioTech / Biopharma / National / National blog main / National top stories / AbCellera / Antibodies / coronavirus / COVID-19 / drug discovery / Eli Lilly / Life Sciences / Partnership / pharma / Therapeutics / Vaccine

AbCellera's Coronavirus “Neutralizing” Antibody Leads Enter Screening

Posted On: Mar 18, 2020   |   Posted By: Xconomy

AbCellera's Coronavirus “Neutralizing” Antibody Leads Enter Screening

Vancouver-based biotech AbCellera Biologics has identified more than 500 antibodies that could potentially be turned into medicines to treat the SARS-CoV-2 novel coronavirus. Now scientists at the National Institutes of Health, with which the company has been working to prepare medical countermeasures for pandemic outbreaks, are testing the candidates to determine which are most potent. It's the latest step in an ambitious proposal by AbCellera and biopharma giant Eli Lilly to spin up an antibody product ready for human testing by the end of July that could potentially treat COVID-19, the respiratory illness caused by the deadly virus...

Continue reading ...